Naltrexone SR/Bupropion SR (Contrave): A New Approach to Weight Loss in Obese Adults (Q35111272)

6 August 2017

title

Naltrexone SR/Bupropion SR (Contrave): A New Approach to Weight Loss in Obese Adults (English)

1 reference

6 August 2017

0 references

0 references

Tehane Ornellas

1

1 reference

6 August 2017

Benjamin Chavez

series ordinal

2

1 reference

6 August 2017

publication date

1 May 2011

1 reference

P & T: journal for formulary management

6 August 2017

published in

1 reference

6 August 2017

volume

36

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

255-262

1 reference

Body-Mass Index and Mortality among 1.46 Million White Adults

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138366

Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138366

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138366

Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138366

Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21785538

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

3138366

1 reference

6 August 2017

1 reference